Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Infant Cardiopulmonary Bypass
NCT02122679Phase 4Withdrawn
- Sponsor
- Emory University
- Start
- Dec 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in congenital heart defect (CHD), sponsored by Emory University. Planned start Dec 2014; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
congenital heart defect (CHD)
Beyond the preview
Go deeper on NCT02122679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122679.